Emcure Pharma
Novo Nordisk partners Emcure Pharma for weight loss medicine Poviztra in India
Emcure Pharma gets Form 483 with two observations for API plant from USFDA
Emcure Pharma shares zoom over 35% in debut trade, closing at Rs 1,364.20
Emcure, Gennova settle litigation with HDT, ink pact to develop mRNA vaccines
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg)
/newsdrum-in/media/media_files/2025/05/22/emcure-pharmaceuticals-namita-thapar-292370.jpg)
/newsdrum-in/media/media_files/2025/11/10/nova-nordisk-poviztra-wegovy-2025-11-10-15-06-14.jpg)
/newsdrum-in/media/media_files/2025/05/22/emcure-pharmaceuticals-namita-thapar-292370.jpg)
/newsdrum-in/media/media_files/EgA0g4c7YvywU2F3QiVq.jpg)
/newsdrum-in/media/media_files/aecv6KdR9NceS2EwGNcb.jpg)
/newsdrum-in/media/post_banners/Q47kMaWrlDfI7baoXICa.jpg)
/newsdrum-in/media/media_files/MsFwy0e8I4I51Tw1GKL1.jpg)
/newsdrum-in/media/media_files/y1LgrDeViZKAEqIYHHr7.jpg)
